Poster A novel AhR inhibitor ‘DA-4505’ enhanced the anti-cancer efficacy in combination with surgery, chemotherapy and pembrolizumab through increasing cytotoxic effects with antigen presentation
페이지 정보
작성자 DAAN
조회 571회 작성일 23-04-18 10:35
조회 571회 작성일 23-04-18 10:35
본문
| Journal | AACR |
|---|---|
| Name | 김동권, 백수정, 표경호 |
| Year | 2023 |
첨부파일
-
Final_AACR2023 poster_DongA_final.pdf (2.3M)
0회 다운로드 | DATE : 2023-04-18 10:35:15
- 이전글OCT-598, a novel EP2/EP4 dual antagonist, promotes anti-tumor immune response in syngeneic mouse tumor models in combination with standard-of-care chemo- and immunotherapies 24.02.16
- 다음글Characterization of immunological heterogeneity in the tumor microenvironment by integrated analyses using single cell RNAseq, spatial RNAseq and multiplex IHC 23.04.18